Inhibition of PCSK9 in familial hypercholesterolaemia

被引：4
|
作者：
Sijbrands, Eric J. G. [1 ,2 ]
机构：
[1] Erasmus MC, Pharmacol Vasc & Metab Dis sect, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Dept Cardiol & Internal Med, Cardiovasc Genet Sect, NL-3000 CA Rotterdam, Netherlands
来源：
LANCET | 2012年 / 380卷 / 9836期
关键词：
APOLIPOPROTEIN-B; CONTROLLED-TRIAL; LDL CHOLESTEROL; DOUBLE-BLIND; STATIN; ATHEROSCLEROSIS; MIPOMERSEN; EZETIMIBE; EFFICACY; THERAPY;
D O I：
10.1016/S0140-6736(12)60814-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [1] PCSK9 inhibition in children with familial hypercholesterolaemia
    Hegele, Robert A.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (10): : 686 - 688
  • [2] Familial hypercholesterolaemia: PCSK9 inhibitors are coming
    Santos, Raul D.
    Watts, Gerald F.
    LANCET, 2015, 385 (9965): : 307 - 310
  • [3] PCSK9 inhibitors for treating familial hypercholesterolaemia
    Hiroshi Mabuchi
    Atsushi Nohara
    Nature Reviews Endocrinology, 2015, 11 : 8 - 9
  • [4] PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia
    Wu, Huaizhu
    Ballantyne, Christie M.
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (07) : 385 - +
  • [5] THERAPY PCSK9 inhibitors for treating familial hypercholesterolaemia
    Mabuchi, Hiroshi
    Nohara, Atsushi
    NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (01) : 8 - 9
  • [6] PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia
    Huaizhu Wu
    Christie M. Ballantyne
    Nature Reviews Cardiology, 2017, 14 : 385 - 386
  • [7] ODYSSEY ESCAPE: is PCSK9 inhibition the Trojan Horse for the use of lipoprotein apheresis in familial hypercholesterolaemia?
    Watts, Gerald F.
    Stefanutti, Claudia
    EUROPEAN HEART JOURNAL, 2016, 37 (48) : 3596 - 3599
  • [8] PCSK9 inhibition in the management of familial hypercholesterolemia
    Ogura, Masatsune
    JOURNAL OF CARDIOLOGY, 2018, 71 (1-2) : 1 - 7
  • [9] PCSK9 inhibitor reduces need for lipoprotein apheresis in familial hypercholesterolaemia
    Gregory B. Lim
    Nature Reviews Cardiology, 2016, 13 (11) : 634 - 634
  • [10] PCSK9 analysis in familial hypercholesterolaemia patients negative for LDLR and APOB mutations
    George, P. M.
    Homer, V. M.
    Laurie, A. D.
    Hurndell, N.
    Scott, R. S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 135 - 135
12345